“Cross-over Effect” in survival curves with immune-checkpoint inhibition: Identifying ideal candidates for immunotherapy-only approaches in specific tumor histologies S Goyal, A Thomas, PA Desai Cancer Research 84 (6_Supplement), 7537-7537, 2024 | | 2024 |
A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion P Desai, A Saksena, PS Dange, R Gupta, S Kapoor, T Singh Blood 130 (Supplement 1), 4958-4958, 2017 | 2 | 2017 |
Abstract CT257: Hyperprogressive disease following bintrafusp alfa and DNA damaging chemotherapy in relapsed small cell lung cancer B Schroeder, N Takahashi, H Yang, R Donahue, Z Skidmore, A Konicki, ... Cancer Research 84 (7_Supplement), CT257-CT257, 2024 | | 2024 |
Abstract CT268: Targeting replication stress and chemotherapy resistance with a combination of sacituzumab govitecan and berzosertib: A phase I clinical trial ML Abel, N Takahashi, P Desai, C Peer, C Redon, S Nichols, R Vilimas, ... Cancer Research 83 (8_Supplement), CT268-CT268, 2023 | | 2023 |
Abstract LB_A10: Efficacy of ATR inhibitor berzosertib plus topotecan or topotecan alone in patients with relapsed small cell lung cancer: A randomized clinical trial N Takahashi, Z Hao, LC Villaruz, J Zhang, J Ruiz, WJ Petty, H Mamdani, ... NaN, LB_A10-LB_A10, 2023 | | 2023 |
Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies VE Mulanovich, PA Desai, UR Popat Aids 30 (17), 2653-2657, 2016 | 17 | 2016 |
An affordable, indigenous polarizer-analyser system with inbuilt retardation plate function to detect birefringence using 3d glasses: An experience DP Anil, DP Sudhir, A Saksena, N Khurana Journal of Clinical and Diagnostic Research: JCDR 10 (1), EC12, 2016 | 1 | 2016 |
ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer CW Schultz, Y Zhang, R Elmeskini, A Zimmermann, H Fu, Y Murai, ... bioRxiv, 2022.12. 16.520783, 2022 | 1 | 2022 |
ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer CW Schultz, Y Zhang, R Elmeskini, A Zimmermann, H Fu, Y Murai, ... EMBO Molecular Medicine 15 (8), e17313, 2023 | 11 | 2023 |
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer CW Schultz, Y Zhang, R Elmeskini, A Zimmermann, H Fu, Y Murai, ... EMBO Molecular Medicine 16 (3), 664-664, 2024 | | 2024 |
Automated detection and segmentation of small cell lung cancer liver metastases on CT. U Chaudhary, PA Desai, N Takahashi, N Lay, PL Choyke, A Thomas, ... Journal of Clinical Oncology 40 (16_suppl), e13555-e13555, 2022 | | 2022 |
Berzosertib plus topotecan vs topotecan alone in patients with relapsed small cell lung cancer: a randomized clinical trial N Takahashi, Z Hao, LC Villaruz, J Zhang, J Ruiz, WJ Petty, H Mamdani, ... JAMA oncology 9 (12), 1669-1677, 2023 | 8 | 2023 |
Bilirubin crystallization in neutrophils in cases of neonatal unconjugated hyperbilirubinemias P Dange, P Desai, R Gupta, T Singh Journal of Applied Hematology 5 (3), 117-118, 2014 | 1 | 2014 |
Breast Cancer in Women Over 65 years- a Review of Screening and Treatment Options AA Desai P Clin Geriatr Med, 0 | 21* | |
Carcinoma breast masquerading as extramedullary plasmacytoma breast: An unusual case report with review of literature N Mahajan, A Saksena, P Desai, S Kaushal, S Jain, R Patel Cancer Treatment Communications 8, 5-7, 2016 | | 2016 |
CD30 Expression and Its Prognostic Significance in De Novo Diffuse Large B Cell Lymphoma Treated with Rituximab-EPOCH J Xu, A Saksena, P Desai, P Lin, CC Yin, G Tang, MJ You, LJ Medeiros, ... LABORATORY INVESTIGATION 96, 386A-386A, 2016 | | 2016 |
CD30 expression and prognostic significance in R-EPOCH–treated patients with diffuse large B-cell lymphoma J Xu, Y Oki, A Saksena, P Desai, P Lin, G Tang, CC Yin, MJ You, ... Human pathology 60, 160-166, 2017 | 12 | 2017 |
Computational analysis reveals similarities and differences between SCLC subtypes A Singh, P Desai, M Pillai, N Agarwal, N Takahashi, A Thomas, MK Jolly bioRxiv, 2021.10. 27.465593, 2021 | | 2021 |
Cyclic‐AMP signalling, MYC and hypoxia‐inducible factor 1 α intersect to regulate angiogenesis in B‐cell lymphoma P Ethiraj, B Sasi, KN Holder, AP Lin, Z Qiu, C Jaafar, A Elkhalili, P Desai, ... British Journal of Haematology 198 (2), 349-359, 2022 | 3 | 2022 |
Dissecting small cell lung cancer subtypes with cell-free DNA fragmentomes. L Rinaldi, ZL Skidmore, B Alipanahi, G Graham, B Chesnick, N Takahashi, ... Journal of Clinical Oncology 41 (16_suppl), 8592-8592, 2023 | | 2023 |